Changes in Buprenorphine and Methadone Supplies in the US During the COVID-19 Pandemic

IMPORTANCE: The opioid crisis has been exacerbated by the COVID-19 pandemic in the US, with concerns over major disruptions to medication treatment of opioid use disorder. OBJECTIVE: To investigate whether the COVID-19 pandemic was associated with disruption of buprenorphine and methadone supplies i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Annie Y., Powell, David, Stein, Bradley D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327579/
https://www.ncbi.nlm.nih.gov/pubmed/35881394
http://dx.doi.org/10.1001/jamanetworkopen.2022.23708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327579/
https://www.ncbi.nlm.nih.gov/pubmed/35881394
http://dx.doi.org/10.1001/jamanetworkopen.2022.23708

Ejemplares similares